The in vitro work confirms the evidence that PAR activation leads to iPLA2-mediated prostaglandin release in human urothelial carcinoma cell line RT4 [30], human bladder microvascular endothelial [59,60], and normal urothelial cells [61]. Here, PLA2G6 is linked to urothelial carcinoma.